Exclusive: Drug firm Ikaria on the block for more than $2 billion - sources

By Greg Roumeliotis and Jessica Toonkel NEW YORK (Reuters) - Ikaria Inc, a private equity and venture capital-backed company whose products are focused on critically ill patients, is exploring a sale that it hopes could value it at more than $2 billion, three people familiar with the matter said this week. Ikaria, whose owners include New Mountain Capital LLC, ARCH Venture Partners LP and Venrock Associates LP, is working with Morgan Stanley and Credit Suisse Group AG on the possible sale, two of the people said. The sources requested anonymity because the sale process is confidential. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/exclusive-drug-firm-ikaria-block-more-2-billion-070209541--sector.html